Table of Contents
Description
Priority Announcements on Fellowship competitions offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas or mandates. Applications are submitted through the October 2008 "2008(10)" competition of the Fellowship: 2008-2009 funding opportunity.
Fellowships provide support for highly qualified candidates at the post-PhD or post-health professional degree stages to add to their experience by engaging in health research either in Canada or abroad.
Funds Available
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
Funds Available for Research in All Areas:
Funds are available for applications in all areas of research that address any important health problem or issue through the October 2008 "2008(10)" competition of the CIHR Fellowship: 2008-2009 funding opportunity.
Funds Available for Research in Specific Areas:
In this competition, funds are available to encourage and support applications in specific areas that are aligned with CIHR's research priority areas and mandates. Information on the research areas to be funded as well as the maximum amounts per grant that can be requested is found in the "Objectives" section.
A. CIHR Research Priority Areas
- Aging
- Aging - Longitudinal Studies
- Clinical Research
- Dystonia (Small Health Organizations Partnership Program)
- Fanconi Anemia (Small Health Organizations Partnership Program)
- Fragile X (Small Health Organizations Partnership Program)
- HIV/AIDS
- Incontinence (Small Health Organizations Partnership Program) REMOVED (Updated: 2008-07-11)
- Knowledge Translation
- Mobility in Aging
- Population Genetics and Genetic Epidemiology
- Regional Partnerships Program - Manitoba
- Regional Partnerships Program - New Brunswick
- Regional Partnerships Program - Newfoundland and Labrador
- Regional Partnerships Program - Prince Edward Island
- Regional Partnerships Program - Saskatchewan
- Thalassemia (Small Health Organizations Partnership Program)
- Transfusion Science
B. Prizes in CIHR Research Priority Areas
- Bisby (Prize)
- BIOTECanada Schering-Plough Canada (Prize)
- Cancer (Prize)
- Knowledge Translation - Elizabeth Dickson KT Fellowship Supplement (Updated: 2008-08-20)
- Schizophrenia (Prize)
C. Priority Announcements announced after the launch
- Huntington Disease (Updated: 2008-08-13)
Top
Objectives
The specific objective of the Fellowship Priority Announcement (Specific Research Areas) is to offer additional sources of funding for highly rated applications that are relevant to specific CIHR research priority areas and mandates.
A. CIHR Research Priority Areas
1. Aging. The CIHR Institute of Aging (CIHR-IA) will fund applications that are determined to be relevant1 to the research priority areas described below:
CIHR-IA will evaluate applications for relevance to research on aging Priority Topics which must be addressed within one relevance form (see "How to Apply").
The maximum amount awarded for a single award is $60,000 per annum for up to three years. CIHR anticipates that approximately two awards will be funded through this competition.
The CIHR-IA will also award to the highest ranked applicant a travel allowance supplement valued at a maximum of $2,500 in year one of the award through the CIHR-IA Recognition Prize in Research on Aging.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
2. Aging - Longitudinal Studies. CIHR, through the Canadian Longitudinal Study on Aging (CLSA), will fund applications that are determined to be relevant to the development, design, planning, data collection and/or analysis health measurement studies with emphasis on the CLSA and similar longitudinal studies.
More information on the objectives and relevant research areas of the Canadian Longitudinal Study on Aging Fellowships can be found on the Institute of Aging website.
The maximum amount awarded for a single award is up to $60,000 per annum for up to two years. CIHR-Institute of Aging anticipates that approximately two awards will be offered through this competition.
Additional Information:
- Candidates are encouraged to consider a supervisor who is a researcher linked to the Canadian Longitudinal Study on Aging, such as the CLSA Principal Investigators, CLSA Theme Leaders and other Key Co-investigators of CLSA, and/or to other national/international longitudinal studies of aging.
- One copy of all published research articles resulting from this Fellowship must be forwarded to the CIHR Institute of Aging
- Given that awardees will be contributing to the knowledge base of the Canadian Longitudinal Study on Aging, they may be called upon by CLSA Principle Investigators or the CIHR Institute of Aging to participate in promotional activities, such as symposia, workshops and newsletters
CIHR-IA will evaluate applications for relevance to the research priorities which must be addressed within one relevance form (see "How to Apply").
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
3. Clinical Research. The CIHR Clinical Research Initiative will fund applications that are determined to be relevant to their research priority area described below:
More information on the research priorities of CIHR-Clinical Research Initiative can be found on their website.
The maximum amount awarded for a single award is up to $60,000 per annum for up to five years. CIHR-Clinical Research Initiative anticipates that two awards will be offered through this competition.
This priority announcement is directed to licensed health professionals3 engaged in clinical research. Candidates must hold a valid Canadian license (full or educational) at the time of application. Canadian licensure must be maintained for the duration of the award.
Clinical Research is that part of the continuum of health research which is conducted on humans or on materials, specimens, or data derived from humans and populations with a focus on:
- Mechanisms of human health and disease.
- Bench to bedside to bench research.
- Clinical trials and observational studies of prevention and therapy.
- Clinical epidemiological studies.
In addition, clinical research may utilize the methods of health care services/systems research and population health research as they relate to clinical encounters.
Additional Information:
- The award is non-renewable.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
4. Dystonia (Small Health Organizations Partnership Program). CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Dystonia Medical Research Foundation of Canada (DMRFC), will fund applications that are determined to be relevant to the research priority areas described below:
- Clinical characterization of dystonias.
- Genetic and pathophysiologic studies striving to reveal their causes.
- Development of novel treatment and rehabilitation options.
More information on the research priorities of the Dystonia Medical Research Foundation of Canada can be found on their Website.
The maximum amount awarded for a single award is $55,000 per annum for up to three years. It is anticipated that one award will be funded through this competition.
Additional Information:
- Award must be held in Canada.
- DMRFC will not pay for parental leave but agrees to extend the term of the award by the duration of the leave.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
5. Fanconi Anemia (Small Health Organizations Partnership Program). CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with Fanconi Canada, will fund applications that are determined to be relevant to the research priority area described below:
More information on the research priorities of Fanconi Canada can be found on their Website.
The maximum amount awarded for a single award is $55,000 per annum for up to five years. It is anticipated that one award will be funded through this competition.
Additional Information:
- Award must be held in Canada.
- Fanconi Canada will not pay for parental leave but agrees to extend the term of the award by the duration of the leave.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
6. Fragile X (Small Health Organizations Partnership Program). CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Fragile X Research Foundation of Canada (FXRFC), will fund applications that are determined to be relevant to the research priority areas described below:
- Fragile X gene therapy, protein replacement therapy, psychopharmacology, nootropic agents, MAPIB, mGluR theory and synaptic plasticity.
More information on the research priorities of Fragile X Research Foundation of Canada (FXRFC) can be found on their Website.
The maximum amount awarded for a single award is $55,000 per annum for up to three years. Approximately four awards will be funded through this competition.
Additional Information:
- Award must be held in Canada.
- Fragile X will not pay for parental leave but agrees to extend the term of the award by the duration of the leave.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
7. HIV/AIDS. The CIHR Institute of Infection and Immunity - HIV/AIDS Research Initiative will fund applications that are determined to be relevant to the research priority areas described below (the primary research focus must be HIV/AIDS):
- Health systems, services and policy.
- Resilience, vulnerability and determinants of health.
- Prevention technologies and interventions.
- Drug development, toxicities and resistance.
- Pathogenesis.
- Issues of co-infection.
More information on the research priorities of the HIV/AIDS Research Initiative can be found on the Institute of Infection and Immunity website. Research in the priority areas described above that focuses on at risk populations including people living with HIV/AIDS, men who have sex with men, injection drug users, Aboriginal Peoples, prison inmates, youth at risk, women at risk and people from countries where HIV is endemic is encouraged.
The maximum amount awarded for a single award is up to $60,000 per annum for up to five years. CIHR anticipates that approximately four awards will be funded through this competition.
Additional Requirements:
- Applications to the HIV/AIDS Research Initiative are sought in two distinct funding streams - Biomedical/Clinical Research and Health Services/Population Health Research. Although projects which display a multidisciplinary approach across all four research pillars are strongly encouraged and accepted, applicants must clearly indicate the most relevant funding stream in the relevance field of their ResearchNet application.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
8. Incontinence (Small Health Organizations Partnership Program). REMOVED (Updated: 2008-07-11)
9. Knowledge Translation (KT). CIHR will fund applications that are determined to be relevant to the research priority areas described below:
- KT Research: increasing understanding of the theory and practice of knowledge translation.
- Measuring KT: developing tools and measures to evaluate the effectiveness and/or impact of KT practices and interventions.
- Moving research into action (doing KT).
CIHR's mandate is to "excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system." The purpose of this funding opportunity is to further strengthen knowledge translation (synthesis, dissemination, exchange and ethically sound application of knowledge) by supporting knowledge translation trainees early in their careers. It is expected that this targeted investment will lead to a better understanding of concepts, theories and practices that underlie effective KT in order to improve the health of Canadians, provide more effective health services and products and strengthen the health care system.
The maximum amount awarded for a single award is $60,000 per annum for up to five years. CIHR anticipates that three awards will be offered through this competition.
More information on the research priorities of the CIHR Knowledge Translation Portfolio can be found on their website.
Additional Information:
- This award will be non-renewable.
- Applications deemed relevant to this priority announcement, which are funded in the CIHR Fellowship Award competition or through this priority announcement will be named "CIHR Knowledge Translation Fellowship Award".
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
10. Mobility in Aging. The CIHR Institute of Aging (CIHR-IA) will fund applications that are determined to be relevant to the Mobility in Aging Initiative.
The maximum amount awarded for a single award is up to $60,000 per annum for up to three years. CIHR-Institute of Aging anticipates that approximately two awards will be offered through this competition.
CIHR-IA will evaluate applications for relevance using the following criteria2 which must be addressed in separate paragraphs within one relevance form (see "How to Apply").
Within the context of the open CIHR Fellowship competition, the CIHR-IA will also award to the highest IA-relevant ranked applicant a travel allowance supplement valued at a maximum of $2,500 in year one of the award through the CIHR-IA Recognition Prize in Research on Aging.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
11. Population Genetics and Genetic Epidemiology. The CIHR Institute of Genetics (CIHR-IG) will fund applications that are determined to be relevant to the research priority areas described below:
- Population genetics, genetic epidemiology and complex diseases.
The IG wishes to fund applications for projects that bridge laboratory-based research with genetic epidemiology. We encourage studies of special or high-risk populations which use novel molecular or statistical approaches or innovative designs.
Suggested research areas include, but are not restricted to:
- Genetic epidemiological studies of diseases in populations with distinct ethnic backgrounds or environmental exposures.
- Developing models for incorporation population history and structure which have implications for the study of genetic aspects of common diseases.
- Efficient designs for cohort studies to detect and model genetic effects and gene-environment interactions.
- Genetic modeling of complex phenotypes that exhibit quantitative variation.
More information on the research priority themes of CIHR-IG can be found in their strategic plan.
The maximum amount awarded for a single award is up to $60,000 per annum for up to four years. CIHR-Institute of Genetics anticipates that one award will be offered through this competition.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
12. Regional Partnerships Program - Manitoba. CIHR, through the Regional Partnerships Program (RPP), in partnership with the Manitoba Health Research Council may fund applications in Manitoba in all four pillars of research, subject to funding ability.
The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. One award is expected to be offered through this competition (subject to the availability of funds).
Additional Information:
- The award must be held in Manitoba.
- The award is non-renewable under the RPP program.
- Recipient will be the top ranked researcher that meets the above criteria.
Please note researchers must submit their applications at least two weeks prior to the CIHR deadline to have their applications vetted by the internal review procedures at MHRC in order for their award to be eligible for consideration for RPP funding.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
13. Regional Partnerships Program - New Brunswick. CIHR, through the Regional Partnerships Program (RPP), in partnership with New Brunswick - RPP may fund applications in all four pillars of health research that contribute to the goal of building health research capacity in New Brunswick, which meet RPP eligibility requirements.
More information on the research priorities of New Brunswick can be found on their website.
The maximum amount awarded for a single award is up to $55,000 per annum for up to two years. Approximately two awards are expected to be offered through this competition (subject to the availability of funds).
Additional Information:
- The award is non-renewable under the RPP program.
- The award must be held in New Brunswick.
- Recipient will be the top ranked researcher that meets the above criteria.
Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures of the New Brunswick RPP Advisory Board a minimum of two weeks prior to submitting their application to CIHR in order for their award to be eligible for consideration for RPP funding.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
14. Regional Partnerships Program - Newfoundland and Labrador. CIHR, through the Regional Partnerships Program (RPP), in partnership with Newfoundland and Labrador - RPP may fund applications in all four pillars of health research in Newfoundland and Labrador, pending funding availability, which meet RPP eligibility requirements.
More information on the research priorities of Newfoundland and Labrador (PDF) can be found on their website.
The maximum amount awarded for a single award is up to $55,000 per annum for up to five years (subject to the availability of funds).
Additional Information:
- The award is non-renewable under the RPP program.
- Trainees must propose a research training program in Newfoundland and Labrador to be eligible for this award.
- Only one trainee will be eligible to receive funding with a single Principle Investigator.
- Recipients will be the top ranked researchers that meet the above criteria.
Please note that researchers must submit their applications at least one month prior to the CIHR deadline to have their applications vetted by the internal review procedures at RPP- Newfoundland and Labrador in order for their grant to be eligible for consideration for RPP funding.
Contact for this process is:
Office of Research and Graduate Studies,
Faculty of Medicine
Memorial University of Newfoundland
Room H-1759, Health Sciences Complex
St. John's, NL
A1B 3V6
Telephone: 709-777-6762
Fax: 709-777-7501
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
15. Regional Partnerships Program - Prince Edward Island. CIHR, through the Regional Partnerships Program (RPP), in partnership with Prince Edward Island - RPP may fund applications that span the four pillars of research that contribute to the goal of building health research capacity in PEI.
The following areas of research strength at UPEI reflect the four pillars:
- Cardiovascular and respiratory health research.
- Metabolism, nutrition and diabetes.
- Human development and cognition.
- Cancer research.
- Applied health services and health promotion.
- Natural products and human health.
- Population health.
More information on the research priorities of Prince Edward Island can be found in the University of Prince Edward Island Strategic Plan.
The maximum amount awarded for a single award is up to $55,000 per annum for up to two years, dependant on the number of applicants. Approximately four awards are expected to be offered through this competition (subject to the availability of funds).
Additional Information:
- Only one trainee per research environment will be eligible to receive funding.
- The award must be held in Prince Edward Island.
- The award is non-renewable under the RPP program.
- Trainees must propose a research training program in Prince Edward Island to be eligible for this award.
- Recipient will be the top ranked researcher that meets the above criteria.
Please note that in order to be considered for RPP funding, researchers must have their applications screened through the internal review procedures at the PEI Health Research Institute a minimum of one month prior to submitting their application to CIHR in order for their award to be eligible for consideration for RPP funding
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
16. Regional Partnerships Program - Saskatchewan. CIHR, through the Regional Partnerships Program (RPP), in partnership with Saskatchewan - RPP may fund highly rated applications in Saskatchewan in all four pillars of research, subject to funding availability.
Fellowships awarded to health professionals for the purpose of doctoral training will be funded for up to three years. Post-doctoral fellows (PDFs) will be funded for up to two years. PDFs who have already received a two-year award from the Saskatchewan Health Research Foundation (SHRF) Research Fellowship Program will only be supported for one year.
The awarded funding will be established at the appropriate minimum amounts set by CIHR regulations.
An award is usually made for one year with a requirement to re-apply to CIHR. Renewal is automatic if the re-application is considered fundable by CIHR (i.e. 3.5 or greater rating). Otherwise the awards are not renewable.
For additional information on eligibility criteria and funding details, please refer to Saskatchewan-CIHR RPP Policies.
Additional Information:
- The award must be held in Saskatchewan, but the project can involve some work outside the province.
- All Fellows must be under the supervision of an investigator holding an appointment at a university in Saskatchewan.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
17. Thalassemia (Small Health Organizations Partnership Program). CIHR through the Small Health Organizations Partnership Program (SHOPP), in partnership with the Thalassemia Foundation of Canada, will fund applications that are determined to be relevant to the research priority areas described below:
- Cardiovascular and respiratory health.
- Metabolism.
- Blood.
More information on the research priorities of the Thalassemia Foundation of Canada can be found on their Website.
The maximum amount awarded for a single award is $55,000 per annum for up to three years. It is anticipated that one award will be funded through this competition.
Additional Information:
- Award must be held in Canada.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
18. Transfusion Science. The CIHR Institute of Circulatory and Respiratory Health and Canadian Blood Services (CBS) will fund applications that are determined to be relevant to the research priority areas described below:
More information on the research priorities of the CIHR-Institute of Circulatory and Respiratory Health and the Canadian Blood Services can be found on their websites.
The maximum amount awarded for a single award is up to $55,000 per annum for up to three years. The CIHR-Institute of Circulatory and Respiratory Health and the Canadian Blood Services anticipates that two awards will be offered through this competition.
Additional Information:
- The award is non-renewable.
- The award must be held in Canada.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
B. Prizes in CIHR Research Priority Areas
19. Bisby (Prize).
Dr. Mark Bisby joined the former Medical Research Council of Canada in 1997 as Director of the Programs Branch. From his arrival in 1997 to his retirement in June 2006, he played an important liaison role with Canada's research community, firstly in ensuring that there was a smooth transition between MRC and CIHR and then creating an environment of research excellence to cultivate the broadened research mandate of CIHR. In honouring Dr. Bisby's commitment to CIHR and the health research community, CIHR offers Fellowship Awards in his name.
An award will be offered to the highest ranking candidates in each of the Fellowship committees in each CIHR Fellowship competition. In addition to receiving the applicable stipend and a research allowance under the fellowship program, awardees will carry the distinction of being branded a Bisby Fellow and will receive a supplement to the research allowance of an additional $5,000. The intent of the additional research allowance is to enable recipients to assert themselves as thought leaders on the national and international research stage through engagement in national or international conferences, workshops or meetings related to the award recipient's research
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
20. BIOTECanada Schering-Plough Canada (Prize).
One award will be offered to the highest ranking candidate who applies to one of the two Fellowship Award competitions each year (October and February), whose research focus is in one or more of the following areas: immunology, infectious and inflammatory diseases, cardiovascular conditions, allergies and/or respiratory problems and who is ranked highly enough to be approved for a regular CIHR Fellowship Award. The CIHR BIOTECanada Schering-Plough Canada Fellowship consists of a $5,000 supplement to the stipend and a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to immunology, infectious and inflammatory diseases, cardiovascular conditions, allergies and respiratory problems research.
Additional Information:
- BIOTECanada is dedicated to the sustainable commercial development of biotechnology innovation in Canada. It is the national industry-funded association with almost 200 member companies representing the broad spectrum of biotech constituents including emerging and established companies in the health, agricultural, and industrial sectors, as well as academic and research institutions and other related organizations.
- Schering-Plough Canada Inc. is a country operation of Schering-Plough Corporation that employs over 850 people across Canada. Schering-Plough Corporation is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by approximately 33,500 people around the world.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
21. Cancer (Prize).
Jean-François St-Denis, PhD (August 14, 1966 - March 2, 2004) joined the Canadian Institutes of Health Research (CIHR) in 2000, after completing a PhD at the University of Montreal and postdoctoral studies at the National Institutes of Health in Bethesda, Maryland and the Hospital for Sick Children in Toronto. CIHR is pleased to honour Dr. St-Denis' courageous struggle against cancer by offering a Fellowship Award in his name. This award is offered to an outstanding individual who is to undertake postdoctoral training in the field of cancer research.
One award will be offered to the highest ranking candidate who applies to one of the two Fellowship Award competitions each year (October and February), whose research focus is on cancer and who is ranked highly enough to be approved for a regular CIHR Fellowship Award. The CIHR Jean-François St-Denis Fellowship consists of a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to cancer research.
Additional Information:
- The recipient of the award will be the top ranked application in the field of cancer research as identified through the results of the October 2008 (2008-10) and February 2009 (2009-02) competitions for the 2008-2009 CIHR Fellowship program.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
22. Knowledge Translation - Elizabeth Dickson KT Fellowship Supplement.
This award supplement is offered to an outstanding individual who is to undertake postdoctoral or post health professional training in the field of Knowledge Translation.
A supplement will be offered to the highest ranked and funded candidate from the October 2008 Fellowship Award competition who has applied to, and been deemed relevant for, the Knowledge Translation Priority Announcement. The Elizabeth Dickson KT Fellowship Supplementconsists of a $5,000 supplement to the research allowance of a regular Fellowship Award. The supplement to the research allowance is intended to be used mainly for travel to national or international conferences, workshops or meetings related to the award recipient's research.
Dr. Elizabeth Dickson played a key role in the launch of the CIHR in the year 2000, leading efforts to meet critical milestones in the mandated transformation. For more information on this prize, see the Knowledge Translation web site.
The maximum amount awarded for a single award supplement is up to $5,000 for one year. CIHR anticipates that one supplement will be offered through this competition.
(Updated: 2008-08-20)
In addition to the standard KT activities of presenting research findings to targeted audiences and producing lay summaries for dissemination, recipients of the KT award supplement are expected to undertake one of the following activities:
- Present at a CIHR summer institute, CIHR lunch and learn session, or KT trainee network event;
- Create a short podcast for posting on the CIHR website; or
- Carry out a clearly defined activity to be proposed to and approved by the Knowledge Synthesis and Exchange Branch.
Associated costs will be covered by CIHR and activities will be undertaken in coordination with the Knowledge Synthesis and Exchange Branch.
Additional Information:
- The award is non-renewable
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
23. Schizophrenia (Prize).
In 1993, Dr. Michael Smith received the Nobel Prize for Chemistry in 1993 for his discovery and development of a crucial technique known as site-directed mutagenesis, used in genetic engineering. His discovery enabled researchers to gain enormous insights into the structure and function of genes and proteins. Throughout his career, Dr. Smith strongly encouraged young people to pursue science as a career, and he has used his prize to promote science, encourage women to pursue interests in science and support research on severe mental illnesses, especially schizophrenia. To honor Dr. Smith's scientific accomplishments and his lifelong promotion of science, CIHR offers a Doctoral Research Award in his name (CIHR Michael Smith Fellowship Award for Research in Schizophrenia).
To be considered eligible for this award, the application must be relevant to the research priority areas described below:
- Genetics, molecular genetics, imaging and biochemistry of the central nervous system with application to schizophrenia.
Additional Information:
- One award will be offered through this competition.
- The recipient of the award will be the top ranked schizophrenia researcher as identified through the results of the October 2008 (2008-10) competition for the 2008-2009 CIHR Fellowship program
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
C. Priority Announcements announced after the launch
(Updated: 2008-08-13)
24. Huntington Disease.
The Huntington Society of Canada (HSC) in partnership with the CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund applications that are determined to be relevant to the research priority areas described below.
- Basic biomedical research in the area of Huntington's Disease.
More information on the research priorities of the Huntington Society of Canada can be found on their website.
The maximum amount awarded for a single award is for $60,000 per annum for up to three years. CIHR anticipates that a minimum of one award will be funded through this competition.
Additional information:
- Award must be held in Canada.
- HSC will not pay for parental leave but agrees to extend the term of the award by the duration of the leave.
For questions about this research initiative and research objectives, see Appendix 1, under "Additional Information". For questions about CIHR funding guidelines, how to apply, and the peer review process, see the "Contact Information" section.
Top
Eligibility
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Specific to CIHR training awards, please refer to the General Guidelines for Training Programs, as well as the Fellowship: 2008-2009 funding opportunity.
Top
Guidelines
This funding opportunity will follow the General Guidelines for Training Programs. Applicants are encouraged to demonstrate the use of Gender and Sex-Based Analysis in applications.
Allowable Costs
The awards consist of a stipend and a research allowance.
For the research allowance, awardees should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities.
Conditions of Funding
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this funding opportunity. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official languages policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this funding opportunity and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA.
Communication Requirements
Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Public Communication and Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes/partners will be identified on the Authorization for Funding and decision letter.
Top
Performance Measurement
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
- contribute to the monitoring, review and evaluation of CIHR's programs, policies and processes by participating in evaluation studies, surveys, workshops, audits and providing data or reports as required for the purpose of collecting information to assess progress and results; and
- encourage their associates, trainees and administration to participate in the monitoring, review and evaluation of CIHR's programs, policies and processes as required.
Top
Review Process and Evaluation
Relevance Review
A. CIHR Research Priority Areas:
CIHR and partner organizations will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described under "CIHR Research Priority Areas" within the "Objectives" section.
Relevance of the applications to the research priorities will be determined in the following manner:
Prior to peer review, CIHR and the partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority area(s) described above.
To conduct relevance review, these representatives will have access to a completed relevance form in addition to anonymized project titles and summaries, provided that applicants have consented to the sharing of information in consideration for other funding opportunities as well as to the sharing of information to observers in completing their ResearchNet application.
Upon completion of peer review, the CIHR and the partner organizations will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "CIHR Research Priority Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.5 will not be funded.
Applications deemed relevant to a priority announcement, which are funded in the regular Fellowship competition or through a priority announcement will be named "Fellowship in the area of [specific research area] research" (e.g. Fellowship in the area of aging research).
Peer review committees will not be informed of applications submitted for funding through this announcement.
B. Prizes in CIHR Research Priority Areas:
Upon completion of peer review, representatives of CIHR and/or partner organizations will receive an anonymized ranking list, funding level and peer review committee recommendations on award term for all applications 1) that are funded in the regular CIHR Fellowship competition(s); and 2) that are identified as relevant through a keyword search. This information will be used to conduct relevance review when required and to determine the recipient(s) of the prize(s). These applications will be selected from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below the regular CIHR Fellowship competition cut-off will not be considered for prizes.
Peer review committees will not be informed of applications submitted for funding through this announcement.
Peer Review
A CIHR peer review committee will evaluate the full applications. The committee may be drawn from one of CIHR's pre-existing committees or may be created specifically for this funding opportunity. Committee members are selected based on suggestions from many sources including the institute(s)/portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP).
Evaluation Criteria
Fellowship Awards are reviewed in accordance with the Guide for Reviewers - CIHR Fellowships.
The following general criteria for evaluating training award applications will be used:
- Achievements and activities of the candidate.
- Characteristics and abilities of the candidate.
- Research training environment.
Top
How to Apply
Note: This funding opportunity requires the use of ResearchNet to apply for funding.
- A step-by-step overview of CIHR's application processes can be found under How to Apply for Funding.
- Applications to this funding opportunity are submitted through the October 2008 "2008(10)" competition of the "Fellowship: 2008-2009" funding opportunity. The application instructions are outlined in the "How to Apply" section of the "Fellowship: 2008-2009" program.
- Reminder to applicants: Please ensure that your application is complete (including all required signatures) and submitted on time to CIHR. Effective September 1, 2008, CIHR will assume no responsibility in following-up with applicants who submit an incomplete application. Incomplete or late applications will not be accepted into the competition.
Additional instructions that must be followed for this funding opportunity:
A. CIHR Research Priority Areas
- Priority announcements for research in specific CIHR priority areas are listed in the "Objectives" section of this funding opportunity, under "CIHR Research Priority Areas."
- To apply for funding through these priority announcements, select the priority announcement title and relevant research area(s) addressed by your research proposal in the "Identify Priority Announcements and Relevant Research Area" section of your ResearchNet application.
- You may request that your application be considered for up to three priority announcement research areas per application, in each Fellowship competition.
B. Prizes in CIHR Research Priority Areas:
- Priority Announcement prizes are listed in the "Objectives" section of this funding opportunity.
- Your application will automatically be entered into Priority Announcement prize competitions. Refer to the "Review Process and Evaluation Criteria" section above for further details. Consideration for funding through priority announcements prizes is in addition to consideration for priority announcement funding in specific research priority areas.
Top
Contact Information
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Fellowships Program Delivery Coordinator
Research Capacity Development
Canadian Institutes of Health Research
Telephone: 613-948-8199 (Updated: 2008-09-08)
Email: fellowships@cihr-irsc.gc.ca
Top
Additional Information
Appendix 1: Contacts for questions about specific priority announcements and their research objectives
1. Aging
For questions about this initiative and research objectives contact:
Sharon Nadeau
Associate, Strategic Initiatives
CIHR Institute of Aging
Canadian Institutes of Health Research
Telephone: 613-946-1270
Fax: 613-954-1800
E-mail: sharon.nadeau@cihr-irsc.gc.ca
2. Aging - Longitudinal Studies
For questions about this initiative and research objectives contact:
Erica Dobson
Project Officer, CIHR Institute of Aging
Canadian Institutes of Health Research
Telephone: 613-946-7656
Fax: 613-954-1800
E-mail: erica.dobson@cihr-irsc.gc.ca
3. Clinical Research
For questions about this initiative and research objectives contact:
Julie Senécal
Team Lead, Clinical Research Initiative
Canadian Institutes of Health Research
Telephone: 613-941-0057
Fax: 613-954-18000
E-mail: julie.senecal@cihr-irsc.gc.ca
4. Dystonia (Small Health Organizations Partnership Program)
For questions about this initiative and research objectives contact:
Allison Forsythe
Project Officer, Partnerships & Citizen Engagement Branch
Canadian Institutes of Health Research
Telephone: 613-941-6696
Fax: 613-954-1800
E-mail: allison.forsythe@cihr-irsc.gc.ca
5. Fanconi Anemia (Small Health Organizations Partnership Program)
For questions about this initiative and research objectives contact:
Allison Forsythe
Project Officer, Partnerships & Citizen Engagement Branch
Canadian Institutes of Health Research
Telephone: 613-941-6696
Fax: 613-954-1800
E-mail: allison.forsythe@cihr-irsc.gc.ca
6. Fragile X (Small Health Organizations Partnership Program)
For questions about this initiative and research objectives contact:
Allison Forsythe
Project Officer, Partnerships & Citizen Engagement Branch
Canadian Institutes of Health Research
Telephone: 613-941-6696
Fax: 613-954-1800
E-mail: allison.forsythe@cihr-irsc.gc.ca
7. HIV/AIDS
For questions about this initiative and research objectives contact:
Jennifer Ralph
Program Officer, HIV/AIDS Research Initiative
Canadian Institutes of Health Research
Telephone: 613-941-4464
Fax: 613-954-1800
E-mail: jennifer.ralph@cihr-irsc.gc.ca
8. Incontinence (Small Health Organizations Partnership Program)
REMOVED (Updated: 2008-07-11)
9. Knowledge Translation (KT)
For questions about this initiative and research objectives contact:
Andrea Smith
Senior KSE Specialist, Knowledge Synthesis and Exchange Branch
Canadian Institutes of Health Research
Telephone: 613-948-2682
Fax: 613-954-1800
E-mail: andrea.smith@cihr-irsc.gc.ca
10. Mobility in Aging
For questions about this initiative and research objectives contact:
Sharon Nadeau
Associate, Strategic Initiatives
CIHR Institute of Aging
Canadian Institutes of Health Research
Telephone: 613-946-1270
Fax: 613-954-1800
E-mail: sharon.nadeau@cihr-irsc.gc.ca
11. Population Genetics and Genetic Epidemiology
For questions about this initiative and research objectives contact:
Dr. Ursula Danilczyk
Assistant Director, CIHR Institute of Genetics
Canadian Institutes of Health Research
Telephone: 416-813-7670
Fax: 416-813-7673
E-mail: ursulaig@sickkids.ca
12. Regional Partnerships Program - Manitoba
For additional information on eligibility criteria and funding details, please contact:
Shannon Rogalski
Manager, Funding Programs
Manitoba Health Research Council
Phone: 204-783-4249
Email: shannon.rogalski@mhrc.mb.ca
Website: http://www.mhrc.mb.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON K1A 0W9
Telephone: 613-952-5728
E-mail: jacqueline.jorge@cihr-irsc.gc.ca
Erik Blache
Senior Advisor, Partnership and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
E-mail: erik.blache@cihr-irsc.gc.ca
13. Regional Partnerships Program - New Brunswick
For questions about the NB RPP Advisory Board review process and criteria, please contact:
John Boyne
Administrator, Medical Research Fund of New Brunswick
P.O. Box 5100
520 King Street
Fredericton, NB E3B 5G8
Telephone: 506-444-3222
Fax: 506-453-2958
Email: john.boyne@gnb.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON K1A 0W9
Telephone: 613-952-5728
E-mail: jacqueline.jorge@cihr-irsc.gc.ca
Erik Blache
Senior Advisor, Partnership and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
E-mail: erik.blache@cihr-irsc.gc.ca
14. Regional Partnerships Program - Newfoundland and Labrador
Contact for this process is:
Office of Research and Graduate Studies
Faculty of Medicine
Memorial University of Newfoundland
Room H-1759, Health Sciences Complex
St. John's, NL A1B 3V6
Telephone: 709-777-6762
Fax: 709-777-7501
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON K1A 0W9
Telephone: 613-952-5728
E-mail: jacqueline.jorge@cihr-irsc.gc.ca
Erik Blache
Senior Advisor, Partnership and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
E-mail: erik.blache@cihr-irsc.gc.ca
15. Regional Partnerships Program - Prince Edward Island
Please contact the following for additional information:
Colleen MacQuarrie
Acting Director Programs & Partnerships
PEI Health Research Institute
University of Prince Edward Island
550 University Avenue
Charlottetown, PE C1A 4P3
Telephone: 902-894-2812
Fax: 902-628-4359
Email: cmacquarrie@upei.ca
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON K1A 0W9
Telephone: 613-952-5728
E-mail: jacqueline.jorge@cihr-irsc.gc.ca
Erik Blache
Senior Advisor, Partnership and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
E-mail: erik.blache@cihr-irsc.gc.ca
16. Regional Partnerships Program - Saskatchewan
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Jacqueline Jorge
Program Delivery Officer, Regional Partnerships Program
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address Locator 4809A
Ottawa, ON K1A 0W9
Telephone: 613-952-5728
E-mail: jacqueline.jorge@cihr-irsc.gc.ca
Erik Blache
Senior Advisor, Partnership and Citizen Engagement
Canadian Institutes of Health Research
Telephone: 613-948-2684
Fax: 613-954-1800
E-mail: erik.blache@cihr-irsc.gc.ca
17. Thalassemia (Small Health Organizations Partnership Program)
For questions about this initiative and research objectives contact:
Allison Forsythe
Project Officer, Partnerships & Citizen Engagement Branch
Canadian Institutes of Health Research
Telephone: 613-941-6696
Fax: 613-954-1800
E-mail: allison.forsythe@cihr-irsc.gc.ca
18. Transfusion Science
For questions about this initiative and research objectives contact:
Katherine Gardner
Project Manager
CIHR Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
Telephone: 613-941-0086
Fax: 613-954-1800
E-mail: katherine.gardner@cihr-irsc.gc.ca
19. Bisby (Prize)
For questions about this initiative and research objectives contact:
Natalie Carrière McGowan
Program Delivery Coordinator, Research Capacity Development
Canadian Institutes of Health Research
Telephone: 613-954-1964
Fax: 613-954-1800
E-mail: natalie.mcgowan@cihr-irsc.gc.ca
20. BIOTECanada Schering-Plough Canada (Prize)
For questions about this initiative and research objectives contact:
Natalie Carrière McGowan
Program Delivery Coordinator, Research Capacity Development
Canadian Institutes of Health Research
Telephone: 613-954-1964
Fax: 613-954-1800
E-mail: natalie.mcgowan@cihr-irsc.gc.ca
21. Cancer (Prize)
For questions about this initiative and research objectives contact:
Natalie Carrière McGowan
Program Delivery Coordinator, Research Capacity Development
Canadian Institutes of Health Research
Telephone: 613-954-1964
Fax: 613-954-1800
E-mail: natalie.mcgowan@cihr-irsc.gc.ca
22. Knowledge Translation - Elizabeth Dickson KT Fellowship Supplement
For questions about this initiative and research objectives contact:
Andrea Smith
Senior KSE Specialist, Knowledge Synthesis and Exchange Branch
Canadian Institutes of Health Research
Telephone: 613-948-2682
Fax: 613-954-1800
E-mail: andrea.smith@cihr-irsc.gc.ca
23. Schizophrenia (Prize)
For questions about this initiative and research objectives contact:
Natalie Carrière McGowan
Program Delivery Coordinator, Research Capacity Development
Canadian Institutes of Health Research
Telephone: 613-954-1964
Fax: 613-954-1800
E-mail: natalie.mcgowan@cihr-irsc.gc.ca
24. Huntington Disease (Updated: 2008-08-12)
For questions about this initiative and research objectives contact:
Don Lamont
Huntington Society of Canada
151 Frederick Street, Suite 400
Kitchener, Ontario N2H 2M2
Telephone: 519-749-8491 ex. 24
E-mail: dlamont@huntingtonsociety.ca
- Aging
CIHR-IA will evaluate for relevance using the following criteria which must be addressed in separate paragraphs within the relevance field of your ResearchNet application:
- Criterion #1: Extent to which the proposal addresses one or more of the five IA priority topics.
- Criterion #2: Extent to which the research and research design address issues of aging and/or the aged are essential elements of the research objectives, hypotheses and analyses (e.g. dynamics of aging, age-relevant models and/or aged subjects; uniqueness of aging or aged population).
- Mobility in Aging
CIHR-IA will evaluate applications for relevance using the following criteria which must be addressed in separate paragraphs within one relevance form (see "How to Apply"):
- Criterion #1: Extent to which the proposal addresses eligible areas of inquiry under the Mobility in Aging Initiative.
- Criterion #2: Extent to which the research and research design address issues of aging and/or the aged are essential elements of the research objectives, hypotheses and analyses (e.g. dynamics of aging, age-relevant models and/or aged subjects; uniqueness of aging or aged population).
- Clinical Research
List of CIHR-Eligible Health Professions:
- Audiologist/Speech-language Pathologist
- Chiropodist/Podiatrist
- Chiropractor
- Dentist/Dental Surgeon
- Registered Dietitian/Nutritionist
- Medical Laboratory Technologist
- Medical Radiation Technologist
- Midwifery
- Naturopath
- Occupational Therapist
- Optometrist
- Pharmacist
- Physician/Surgeon
- Physiotherapist
- Psychologist
- Registered Nurse
- Registered Psychiatric Nurse
- Respiratory Therapy
- Social Worker
- Veterinarian
Notes:
- To be considered eligible for CIHR programs, the health profession must require at least a Bachelor's degree for licensure in Canada and be regulated by provincial legislation.
- The provincial legislation regarding licensing requirements for the above professions will vary from province to province.
- All health professionals in one of the disciplines listed above and licensed to practice in Canada are eligible to be considered for the higher stipend level under the CIHR Fellowships program and when being paid from a CIHR grant.
Top
| 
